St. Jude Medical (St. Paul, Minnesota) reported FDA clearance of its EnSite Fusion Registration Module, new software designed to aid in creating detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including atrial fibrillation (AF).